Quant Biomarkers AG is a data-driven biotechnology company that develops quantitative biomarkers for assessing human longevity and personalized biomarker panels for early detection of age-related chronic diseases. The company builds AI-based risk-prediction algorithms, tissue-specific diagnostic panels, personalized intervention protocols, and digital-twin applications.
AI-generated
Comparisons
Quant Biomarkers AG in comparison
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.